BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29803640)

  • 21. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
    Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
    J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous lymphoma: Kids are not just little people.
    Ferenczi K; Makkar HS
    Clin Dermatol; 2016; 34(6):749-759. PubMed ID: 27968935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased Levels of Plasma Epstein Barr Virus DNA Identify a Poor-Risk Subset of Patients With Advanced Stage Cutaneous T-Cell Lymphoma.
    Haverkos BM; Gru AA; Geyer SM; Bingman AK; Hemminger JA; Mishra A; Wong HK; Pancholi P; Freud AG; Caligiuri MA; Baiocchi RA; Porcu P
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl(Suppl):S181-S190.e4. PubMed ID: 27521316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of diagnostic criteria between primary cutaneous anaplastic large-cell lymphoma and CD30-rich transformed mycosis fungoides; a study of 66 cases.
    Fauconneau A; Pham-Ledard A; Cappellen D; Frison E; Prochazkova-Carlotti M; Parrens M; Dalle S; Joly P; Viraben R; Franck F; Ingen-Housz-Oro S; Giacchero D; Jullié ML; Vergier B; Merlio JP; Beylot-Barry M
    Br J Dermatol; 2015 Jun; 172(6):1547-1554. PubMed ID: 25645336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic Approaches to Biomarker Discovery in Cutaneous T-Cell Lymphoma.
    Ion A; Popa IM; Papagheorghe LM; Lisievici C; Lupu M; Voiculescu V; Caruntu C; Boda D
    Dis Markers; 2016; 2016():9602472. PubMed ID: 27821903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FoxP3-positive T cell lymphoma arising in non-HTLV1 carrier: clinicopathological analysis of 11 cases of PTCL-NOS and 2 cases of mycosis fungoides.
    Satou A; Asano N; Kato S; Katsuya H; Ishitsuka K; Elsayed AA; Nakamura S
    Histopathology; 2016 Jun; 68(7):1099-108. PubMed ID: 26426838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic Reprogramming Strategies to Reverse Global Loss of 5-Hydroxymethylcytosine, a Prognostic Factor for Poor Survival in High-grade Serous Ovarian Cancer.
    Tucker DW; Getchell CR; McCarthy ET; Ohman AW; Sasamoto N; Xu S; Ko JY; Gupta M; Shafrir A; Medina JE; Lee JJ; MacDonald LA; Malik A; Hasselblatt KT; Li W; Zhang H; Kaplan SJ; Murphy GF; Hirsch MS; Liu JF; Matulonis UA; Terry KL; Lian CG; Dinulescu DM
    Clin Cancer Res; 2018 Mar; 24(6):1389-1401. PubMed ID: 29263182
    [No Abstract]   [Full Text] [Related]  

  • 28. Granulomatous slack skin disease: a review, in comparison with mycosis fungoides.
    Shah A; Safaya A
    J Eur Acad Dermatol Venereol; 2012 Dec; 26(12):1472-8. PubMed ID: 22435618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histopathology and genetics of cutaneous T-cell lymphoma.
    Smoller BR; Santucci M; Wood GS; Whittaker SJ
    Hematol Oncol Clin North Am; 2003 Dec; 17(6):1277-311. PubMed ID: 14710885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma.
    Gerami P; Rosen S; Kuzel T; Boone SL; Guitart J
    Arch Dermatol; 2008 Jun; 144(6):738-46. PubMed ID: 18559762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.
    Lian CG; Xu Y; Ceol C; Wu F; Larson A; Dresser K; Xu W; Tan L; Hu Y; Zhan Q; Lee CW; Hu D; Lian BQ; Kleffel S; Yang Y; Neiswender J; Khorasani AJ; Fang R; Lezcano C; Duncan LM; Scolyer RA; Thompson JF; Kakavand H; Houvras Y; Zon LI; Mihm MC; Kaiser UB; Schatton T; Woda BA; Murphy GF; Shi YG
    Cell; 2012 Sep; 150(6):1135-46. PubMed ID: 22980977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of helper T cell master regulators in inflammatory dermatoses and primary cutaneous T-cell lymphomas: diagnostic implications.
    Hsi AC; Lee SJ; Rosman IS; Carson KR; Kelley A; Viele V; Pang X; Musiek A; Schaffer A
    J Am Acad Dermatol; 2015 Jan; 72(1):159-67. PubMed ID: 25440432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of expression of 5-hydroxymethylcytosine in CD30-positive cutaneous lymphoproliferative disorders.
    De Souza A; Tinguely M; Pfaltz M; Burghart DR; Kempf W
    J Cutan Pathol; 2014 Dec; 41(12):901-6. PubMed ID: 25353265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
    Vidulich KA; Talpur R; Bassett RL; Duvic M
    Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Constitutive expression of NF-kappa B is a characteristic feature of mycosis fungoides: implications for apoptosis resistance and pathogenesis.
    Izban KF; Ergin M; Qin JZ; Martinez RL; Pooley RJ JR; Saeed S; Alkan S
    Hum Pathol; 2000 Dec; 31(12):1482-90. PubMed ID: 11150373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localization of clonal T cells to the epidermis in cutaneous T-cell lymphoma.
    Fivenson DP; Hanson CA; Nickoloff BJ
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):717-23. PubMed ID: 7929915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon in the treatment of cutaneous T-cell lymphoma.
    Olsen EA
    Dermatol Ther; 2003; 16(4):311-21. PubMed ID: 14686974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome.
    Nguyen GH; Olson LC; Magro CM
    Ann Diagn Pathol; 2017 Jun; 28():54-59. PubMed ID: 28648940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Latest insights into pathogenesis of mycosis fungoides and cutaneous T-cell lymphoma.
    McGirt LY
    G Ital Dermatol Venereol; 2017 Apr; 152(2):158-168. PubMed ID: 27982549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.